Table 2 Treatment uptake as defined by percentage of hepatitis C antibody-positive study participants who received treatment
Author, year | % treated (# treated/# of treatment candidates) | SVR (%) (# with sustained viral response/# treated) |
|---|---|---|
Cournot et al, 2004 | 36% (81/225) | Intent-to-treat: 26% (26/99)1 |
Crespo et al, 2001 | 64% (268/416) | NA |
Cullen et al, 2007 | 3% (3/104) | NA |
Defossez et al, 2008 | 16% (13/84)2 | NA |
Grando-Lemaire et al, 2002 | 12% (27/225) | Intent-to-treat: 19% (5/27) As-treated: 33% (5/15) |
Jack et al, 2009 | 17% (30/174) | Intent-to-treat: 62% (13/21) As-treated: 77% (13/17) |
Jowett et al, 2000 | 20% (50/253) | Intent-to-treat: 36% (18/50) |
Kristensen et al, 2009 | 4% (6/160) | NA |
Lindenburg et al, 2011 | 21% (58/277) | Intent-to-treat: 65% (37/57) As-treated: 77% (37/48) |
Schulte et al, 2010 | 9% (26/301) | Intent-to-treat: 69% (18/26) As-treated: 86% (18/21) |